The Pulse
Credo Health buys Affineon and relaunches as Pajama.ai
Credo Health has acquired Affineon Health and relaunched as Pajama.ai, an AI assistant for clinical record preparation and administrative work. The company says the product combines record retrieval with lab and prescription workflows.

Credo Health has acquired Affineon Health and relaunched as Pajama.ai, combining patient record preparation with tools for handling lab results and prescription renewals. The AI assistant is aimed at reducing the administrative work doctors take home, according to the company's announcement on November 16.
The terms of the acquisition were not disclosed. The product is offered as a monthly subscription and works within providers' existing electronic health record workflows.
Work before and after visits
The company takes its name from “pajama time,” the after-hours work providers spend on electronic health records, including reviewing charts, signing off on lab results and approving refills. Federal data cited in the release indicates that one in three family physicians still spend three or more hours a day on after-hours documentation.
Credo's technology retrieves medical records and assembles a patient's longitudinal record. Its insight engine analyzes that record to surface information and suggestions for providers, including suspected conditions, gaps in care, medication issues, overdue screenings and abnormal trends.
Affineon's technology handles work across lab results, prescription renewals and encounter workflows. The company gives examples including preparing a chart, emailing a patient about normal test results and removing duplicate prescription renewal requests.
Time-savings claims
Pajama says the product automates 40% to 60% of inbox messages and reduces chart preparation time by three to five minutes per patient. The combined business serves more than 200 clinical groups, 3,000 doctors and 5 million patients, according to the announcement.
Its website models potential savings of up to 40 hours a month per provider but says the combined estimate has not been validated in a Pajama time study. The calculation assumes 78 eligible office and telehealth visits per week, five minutes saved per visit and a separate 3.5 hours of weekly inbox savings, using a four-week month.
Those assumptions include no overlapping tasks or extra review time, and actual savings depend on workload, eligibility and workflow, the website says. It also describes an inbox report from a Florida-based practice that sampled nine providers over nine calendar days; processing a renewal did not necessarily mean it bypassed clinician review.
In the announcement, Affineon customer Mia M. Painter, chief operating officer of San Marcos Family Medicine, said the practice had seen an inbox-volume reduction of more than 50% across the board since implementation. The release also included feedback from Leslie Chiang of Peachtree Medical Center, a Chart Prep user, who said the insights often changed her management on the spot.
Leadership and rollout
Carm Huntress remains Pajama's CEO. Former Affineon CEO Evan Grossman becomes chief product officer and will lead the combined product roadmap.
Grossman said Affineon customers would not see changes to the tools they currently use and that the combined company could bring Chart Prep to practices already using its inbox automation. The product is scheduled to debut at HLTH 2026, which runs November 15–18 at The Venetian Expo in Las Vegas.
Sources
Related stories
- FDA clears Bracco and Avicenna.AI aneurysm imaging software
- GoodRx connects prescription prices to Gemini for healthcare preview
- Aimbient says Stanford-led study found no significant gap between AI and manual OR timestamps
- Dyania and Nvidia team up on clinical AI inside hospital networks
- Pew Brief Revisits Americans’ Unease With Healthcare AI